Does TREPROSTINIL Cause Pulmonary fibrosis? 226 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 226 reports of Pulmonary fibrosis have been filed in association with TREPROSTINIL (TYVASO). This represents 0.3% of all adverse event reports for TREPROSTINIL.
226
Reports of Pulmonary fibrosis with TREPROSTINIL
0.3%
of all TREPROSTINIL reports
78
Deaths
113
Hospitalizations
How Dangerous Is Pulmonary fibrosis From TREPROSTINIL?
Of the 226 reports, 78 (34.5%) resulted in death, 113 (50.0%) required hospitalization, and 10 (4.4%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 226 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which TREPROSTINIL Alternatives Have Lower Pulmonary fibrosis Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE